Clinics' Stem Cell Treatments Endanger Patients, DOJ Says

Law360 (May 6, 2021, 10:47 PM EDT) -- The U.S. Department of Justice is asking a California federal judge to stop a pair of clinics from offering experimental stem cell treatments without approval from the U.S. Food and Drug Administration, arguing that the clinics are violating the law and endangering patients.

During a court trial that began this week, the government told U.S. District Judge Jesus G. Bernal that California Stem Cell Treatment Center Inc., Cell Surgical Network Corp. and their owners are using unapproved, experimental procedures to treat a variety of diseases and conditions, including cancer, arthritis, macular degeneration and stroke.

In their treatments, the clinics remove fat...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!